Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)

Q32 Bio's Long-Term Investments history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2025.

• In Q1 2025, Long-Term Investments fell 46.53% year-over-year to $2.5 million; the TTM figure through Mar 2025 stood at $2.5 million (down 46.53% YoY), while the FY2024 annual figure was $2.6 million, changed N/A from the prior year.
• Long-Term Investments was $2.5 million for Q1 2025 at Q32 Bio, down from $2.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $30.6 million in Q1 2022 to a low of $2.5 million in Q1 2025.
• Historically, Long-Term Investments has averaged $15.2 million across 4 years, with a median of $15.7 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Long-Term Investments retreated 24.93% in 2023, then sank 81.43% in 2024.
• A 4-year view of Long-Term Investments shows it stood at $25.8 million in 2022, then tumbled by 45.77% to $14.0 million in 2023, then tumbled by 81.43% to $2.6 million in 2024, then retreated by 2.85% to $2.5 million in 2025.
• The last three Long-Term Investments figures came in at $2.5 million (Q1 2025), $2.6 million (Q4 2024), and $2.6 million (Q3 2024), per Business Quant data.